Abstract
Namalva, a human B cell lymphoma line, produced a factor with a molecular weight of ~60,000 which enhanced the proliferation of normal activated human B lymphocytes. The factor also enhanced the proliferation of certain B cell lines. It can be distinguished physiologically and biochemically from other lymphokines known to enhance B cell proliferation, namely, interleukin (IL) 1, IL 2, and interferon. The production of B cell growth factor by B cell tumor lines may contribute to their ability to grow autonomously and may reflect an important component of the neoplastic potential of the cell. B cell growth factor produced by tumors may also affect normal cells in vivo.
| Original language | English |
|---|---|
| Pages (from-to) | 732-739 |
| Number of pages | 8 |
| Journal | Journal of Clinical Investigation |
| Volume | 75 |
| Issue number | 2 |
| DOIs | |
| State | Published - 1985 |
Fingerprint
Dive into the research topics of 'Human B lymphoma cell line producing B cell growth factor'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver